Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort descending
Perkins, Susan M Indiana Univ-Purdue Univ At Indianapolis Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Mao, Jun J Sloan-Kettering Inst Can Research Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Rogers, Laura Q University Of Alabama At Birmingham Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Smith, Ellen Mary Lavoie University Of Alabama At Birmingham Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Washington, Karla Washington University Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Hui, David University Of Tx Md Anderson Can Ctr Strategies for Persistent Agitated Delirium in Palliative Care PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Kolb, Noah Allan University Of Vermont & St Agric College Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Sehgal, Ashwini Case Western Reserve University Pain and Immobility After Breast Cancer Surgery: A Community-Based Randomized Controlled Trial of Myofascial Massage Treatment PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Bylund, Carma L. University Of Florida Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators PAR-18-869: Modular R01s in Cancer Control and Population Sciences
Salvemini, Daniela Saint Louis University Fingolimod and Ozanimod for the treatment and prevention of chemobrain PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Hanks, Brent Allen Duke University Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Robien, Kimberly Z George Washington University Body composition and chemotherapy toxicity among women being treated for breast cancer PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies
Strati, Paolo University Of Tx Md Anderson Can Ctr Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies

Pages